SLAS Boston is expensive.
Booth space. Freight. Travel. Hotels. Sponsorships. Swag.
For many life science companies, the total investment quietly creeps into six figures.
The real question executives should be asking right now isn’t:
“How was the show?”
It’s:
Did it move revenue?
If you can’t clearly point to qualified meetings, pipeline progression, or near-term deals directly tied to SLAS activity, then the event was not a sales driver. It was a branding expense.
And branding is fine.
If that was the strategy.
The problem is that most companies attend SLAS claiming it’s about business development, when in reality, there is no real commercial plan behind it.
Where SLAS ROI Breaks Down
After reviewing dozens of life science conference strategies, the failure points are surprisingly consistent.
1. No Pre-Show Targeting
Waiting for traffic is not a strategy. High-performing teams book meetings before they ever land in Boston. They target accounts, reach out, and create a reason to meet.
2. Booth Messaging That Explains Instead of Engages
If your booth looks like a scientific poster session, you’re losing attention. Scientists and executives alike need clarity and relevance in seconds.
3. Sales Teams Without a Qualification Playbook
Answering questions is not selling. Strong teams control the conversation, qualify quickly, and secure clear next steps.
4. Badge Scans Treated as Pipeline
A badge scan is a contact. Not an opportunity. Without qualification and ownership, most of those leads go nowhere.
5. Post-Show Follow-Up Drift
No timeline. No accountability. No metrics.
“Let’s follow up next week” turns into forgotten CRM entries.
Conferences Don’t Fail. Execution Does.
SLAS is not the problem. It’s one of the most concentrated gatherings of lab automation, tools, and biotech innovators in the world. The opportunity is real.
But opportunity without structure produces inconsistent results.
High-performing life science organizations treat conferences as part of a larger commercialization system. Pre-targeted outreach. Defined messaging. Trained sales behavior. Structured follow-up. Measurable KPIs.
That’s how events become revenue accelerators instead of expensive rituals.
If your team exhibited at SLAS and you’re not completely confident in what worked and what didn’t, that’s not a criticism. It’s an opportunity.
The real competitive advantage is not going to more shows.
It’s executing them better.
Reach out for a no-cost analysis of your Pre-to-Post conference strategy!
Stephen Manobianco
Managing Director
PSG Life Sciences